CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
CervoMed Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.31+0.07 (+3.12%)
Close on Oct 19, 2026
- Market cap
- $23.66M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$4.01MFY2025, +14.9% a year since FY2011